Skip to content
Weight Research

Weight Management

Research peptides studied for their roles in GLP-1 receptor agonism, appetite regulation, incretin signaling, and metabolic rate modulation in preclinical and clinical weight management models.

Buy 3, Save 30%bestseller
Sem
Lyophilized Powder
99%

The weight loss revolution — the same molecule in Ozempic that helps millions lose 15-20% of body weight by silencing food cravings and resetting appetite at the brain level.

  • Lose 15-20% of body weight without willpower or starvation
  • Completely eliminates food noise and constant cravings
$98.99
Buy 2+, Save 20%bestseller
Sem
Lyophilized Powder
99%

Extended semaglutide supply for serious weight loss — 6mg for longer protocols. The compound behind the biggest weight loss transformation in medical history.

  • Double-dose for sustained weight loss programs
  • 15-20% body weight reduction documented in trials
$142.99
Buy 2+, Save 15%trending
Ret
Lyophilized Powder
99%

The most powerful weight loss compound ever studied — triple-receptor agonist that achieved 24% body weight loss in trials, outperforming semaglutide by hitting THREE metabolic pathways.

  • Triple-action weight loss — targets GLP-1, GIP, AND glucagon receptors
  • 24% body weight loss in trials — MORE than semaglutide
$189.99
Buy 3, Save 30%trending
Ret
Lyophilized Powder
99%

Entry dose of the most powerful weight loss peptide in existence — starter Retatrutide for those beginning the triple-agonist protocol that's making Ozempic look like last gen.

  • Triple-agonist technology — next generation beyond Ozempic
  • Starter dose for the most effective weight loss peptide available
$109.99
Buy 3, Save 30%
AOD
Lyophilized Powder
99%

The fat-burning fragment of growth hormone — targets and destroys stubborn body fat (especially belly fat) without touching muscle, blood sugar, or hormone levels.

  • Burns fat without affecting blood sugar or growth hormone levels
  • Targets stubborn belly fat specifically
$52.79
Buy 3, Save 30%
Cag
Lyophilized Powder
99%

The semaglutide amplifier — a long-acting amylin that pairs with GLP-1 drugs to supercharge weight loss. Part of the CagriSema combination that's the next breakthrough.

  • Long-acting amylin analog for appetite suppression
  • Pairs with semaglutide for enhanced weight loss (CagriSema)
$115.99
Buy 2+, Save 15%new
Sem
Lyophilized Powder
99%
Blend

The nuclear option for weight loss — three of the most powerful metabolic compounds combined into one protocol. Hits every appetite and fat-burning pathway known to science.

  • Triple-compound weight loss protocol in one preparation
  • Combines semaglutide + cagrilintide + retatrutide mechanisms
$299.99
Buy 3, Save 30%
Maz
Lyophilized Powder
99%

Dual-action fat burner — hits both GLP-1 and glucagon receptors for aggressive fat loss, with special effectiveness against dangerous liver fat and NAFLD.

  • Dual GLP-1/glucagon agonist for aggressive fat loss
  • Particularly effective against liver fat (NAFLD)
$107.99
Buy 3, Save 30%
Tes
Oral Capsules
99%

Tesofensine 500mcg

500mcg × 60 Capsules

The appetite killer that boosts your mood — blocks reuptake of three feel-good neurotransmitters, eliminating hunger while giving you energy and focus. Oral, no injection.

  • Twice as effective as current weight loss drugs in clinical trials
  • Works through dopamine/serotonin/norepinephrine — triple reuptake
$182.99
Buy 3, Save 30%
Set
Lyophilized Powder
99%

Melanocortin appetite control — targets the brain's MC4R hunger circuits (the same system PT-141 uses for arousal), reducing food obsession while potentially boosting libido.

  • FDA-approved for genetic obesity (MC4R pathway)
  • Reduces hunger in leptin-resistant individuals
$73.99

About Weight Management Research

The Weight Management collection features the most actively researched compounds in modern obesity science. Semaglutide, a GLP-1 receptor agonist, has generated unprecedented clinical interest for its effects on appetite suppression and glycemic control. Retatrutide is a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. AOD 9604 is a modified fragment of human growth hormone studied for lipolytic activity without the growth-promoting effects of full-length hGH. Cagrilintide is a long-acting amylin analog under investigation for synergistic weight reduction. Tesofensine is a triple monoamine reuptake inhibitor studied for central appetite suppression. This category serves researchers at the forefront of metabolic disease and obesity pharmacology.